Page last updated: 2024-08-21

isoxazoles and win 54954

isoxazoles has been researched along with win 54954 in 18 studies

Research

Studies (18)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.56)18.7374
1990's15 (83.33)18.2507
2000's2 (11.11)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
See, DM; Tilles, JG2
Akullian, V; Bailey, TR; Carabateas, PM; Cutcliffe, D; Diana, GD; Eissenstat, MA; Kowalczyk, PJ; Mallamo, JP; Pevear, DC1
Charman, SA; Charman, WN; Dutko, FJ; Pouton, CW; Rogge, MC; Wilson, TD1
Diana, GD; Dutko, FJ; Fox, MP; McKinlay, MA1
Diana, GD; Dutko, FJ; McKinlay, MA; Otto, MJ; Rogge, MC; Woods, MG1
Aldi, C; Aldous, DJ; Aldous, SC; Diana, GD; Draper, T; Dutko, FJ; Nitz, TJ; Pevear, DC; Robinson, DT; Rudewicz, P1
Bailey, TR; Cutcliffe, D; Diana, GD; Giranda, V; Mallamo, JP; Nitz, TJ; Oglesby, RC; Vescio, N; Volkots, DL; Wetzel, J1
Andries, K; Chapman, MS; Diana, GD; Gong, ZX; Kim, KH; Kremer, MJ; Minor, I; Oliveira, MA; Rossmann, MG; Willingmann, P1
Dutko, FJ; Goldstein, NH; Hayden, FG; Lockwood, G; Turner, RB1
Fohlman, J; Friman, G; Ilbäck, NG; Pauksen, K; Stålhandske, T; Wesslén, L1
Fohlman, J; Friman, G; Ilbäck, NG; Pauksen, K1
Eggertsen, G; Ehrnst, A; Fohlman, J; Friman, G; Hyypiä, T; Ilbäck, NG; Pauksen, K1
Borcherding, WR; Dick, EC; Galagan, DM; Gern, JE; Joseph, B1
Grumbach, IM; Heim, A; Müller, G; Pfetzing, U1
Heino, J; Huttunen, P; Hyypiä, T; Nissinen, L; Vihinen, P1
Fohlman, J; Harvala, H; Hyypiä, T; Ilbäck, NG; Kytö, V; Saraste, A; Vuorinen, T1
Egan, JA; Filer, CN; Nugent, RP1

Trials

2 trial(s) available for isoxazoles and win 54954

ArticleYear
Self-emulsifying drug delivery systems: formulation and biopharmaceutic evaluation of an investigational lipophilic compound.
    Pharmaceutical research, 1992, Volume: 9, Issue:1

    Topics: Administration, Oral; Animals; Capsules; Dogs; Drug Delivery Systems; Drug Evaluation, Preclinical; Drugs, Investigational; Excipients; Gelatin; Injections, Intravenous; Isoxazoles; Lipids; Male; Particle Size; Polyethylene Glycols; Postural Balance

1992
Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:2

    Topics: Adult; Antiviral Agents; Double-Blind Method; Humans; Isoxazoles; Middle Aged; Picornaviridae Infections; Rhinovirus

1993

Other Studies

16 other study(ies) available for isoxazoles and win 54954

ArticleYear
Treatment of Coxsackievirus A9 myocarditis in mice with WIN 54954.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:2

    Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Enterovirus; Isoxazoles; Male; Mice; Myocarditis; Myocardium; Organ Size

1992
Antirhinoviral activity of heterocyclic analogs of Win 54954.
    Journal of medicinal chemistry, 1992, Nov-27, Volume: 35, Issue:24

    Topics: Antiviral Agents; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Isoxazoles; Molecular Structure; Rhinovirus; Structure-Activity Relationship; Tetrazoles

1992
Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
    Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:6

    Topics: Antiviral Agents; Capsid; Cells, Cultured; Dose-Response Relationship, Drug; Half-Life; Humans; Isoxazoles; Kinetics; Microbial Sensitivity Tests; Rhinovirus

1991
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
    Antimicrobial agents and chemotherapy, 1989, Volume: 33, Issue:12

    Topics: Animals; Animals, Suckling; Antiviral Agents; Coxsackievirus Infections; Culture Media; Echovirus Infections; Female; Isoxazoles; Mice; Mice, Inbred ICR; Oxazoles; Picornaviridae; Rhinovirus; Viral Plaque Assay; Virus Replication

1989
Picornavirus inhibitors: trifluoromethyl substitution provides a global protective effect against hepatic metabolism.
    Journal of medicinal chemistry, 1995, Apr-14, Volume: 38, Issue:8

    Topics: Animals; Antiviral Agents; Chlorofluorocarbons, Methane; Chromatography, High Pressure Liquid; Computer Graphics; Haplorhini; Isoxazoles; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microsomes, Liver; Picornaviridae; Spectrophotometry, Infrared

1995
WIN 54954 treatment of mice infected with a diabetogenic strain of group B coxsackievirus.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:8

    Topics: Animals; Antiviral Agents; Autoantibodies; Base Sequence; Coxsackievirus Infections; Diabetes Mellitus, Experimental; Enterovirus B, Human; Glucose Tolerance Test; Insulin; Islets of Langerhans; Isoxazoles; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Molecular Sequence Data; Pancreas; RNA, Viral; Time Factors

1993
Antipicornavirus activity of tetrazole analogues related to disoxaril.
    Journal of medicinal chemistry, 1993, Oct-29, Volume: 36, Issue:22

    Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Sequence Data; Picornaviridae; Rhinovirus; Structure-Activity Relationship; Tetrazoles

1993
A comparison of the anti-rhinoviral drug binding pocket in HRV14 and HRV1A.
    Journal of molecular biology, 1993, Mar-05, Volume: 230, Issue:1

    Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Conserved Sequence; Drug Design; Isoxazoles; Models, Molecular; Molecular Sequence Data; Pyridazines; Rhinovirus; Sequence Alignment; Serotyping; Structure-Activity Relationship

1993
Effects of the antiviral WIN 54954 and the immune modulator LS 2616 on cachectin/TNF and gamma-interferon responses during viral heart disease.
    Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 88

    Topics: Adjuvants, Immunologic; Animals; Antiviral Agents; Coxsackievirus Infections; Enterovirus B, Human; Female; Hydroxyquinolines; Interferon-gamma; Isoxazoles; Mice; Mice, Inbred BALB C; Myocarditis; Tumor Necrosis Factor-alpha

1993
Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.
    Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 88

    Topics: Animals; Antiviral Agents; Coxsackievirus Infections; Dosage Forms; Enterovirus B, Human; Female; Isoxazoles; Mice; Mice, Inbred BALB C; Myocarditis; Pharmaceutical Vehicles

1993
Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis.
    Circulation, 1996, Nov-01, Volume: 94, Issue:9

    Topics: Animals; Antibodies, Viral; Antiviral Agents; Blotting, Northern; Complement C3; Complement Factor B; Complement System Proteins; Coxsackievirus Infections; Enterovirus; Enterovirus B, Human; Isoxazoles; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Inbred CBA; Myocarditis; Neutralization Tests; RNA, Messenger; Survival Analysis

1996
Rhinovirus inhibits antigen-specific T cell proliferation through an intercellular adhesion molecule-1-dependent mechanism.
    The Journal of infectious diseases, 1996, Volume: 174, Issue:6

    Topics: Antigen Presentation; Antigens, Viral; Antiviral Agents; Cells, Cultured; Chickenpox; Cytotoxicity, Immunologic; HeLa Cells; Humans; Intercellular Adhesion Molecule-1; Interleukin-2; Isoxazoles; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocyte Activation; Mitogens; Picornaviridae Infections; Pollen; Protein Binding; Rhinovirus; Streptokinase; T-Lymphocytes; Tetanus Toxoid; Tumor Necrosis Factor-alpha

1996
Antiviral activity of WIN 54954 in coxsackievirus B2 carrier state infected human myocardial fibroblasts.
    Antiviral research, 1998, Volume: 37, Issue:1

    Topics: Animals; Antiviral Agents; Carrier State; Cells, Cultured; Chlorocebus aethiops; Coxsackievirus Infections; Dose-Response Relationship, Drug; Enterovirus B, Human; Fibroblasts; Heart; Humans; In Situ Hybridization; Isoxazoles; Polymerase Chain Reaction; RNA-Directed DNA Polymerase; Vero Cells; Viral Plaque Assay; Virus Replication

1998
Echovirus 1 infection induces both stress- and growth-activated mitogen-activated protein kinase pathways and regulates the transcription of cellular immediate-early genes.
    Virology, 1998, Oct-10, Volume: 250, Issue:1

    Topics: Animals; Antiviral Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cell Adhesion; Collagen; Enterovirus B, Human; Enzyme Inhibitors; Gene Expression Regulation, Viral; Genes, Immediate-Early; Haplorhini; Humans; Isoxazoles; Kidney; Phosphorylation; Poliovirus; Protein Biosynthesis; Proto-Oncogenes; Receptors, Virus; RNA, Messenger; Sarcoma, Experimental; Semliki forest virus; Transcription Factor AP-1; Transcription, Genetic; Tumor Cells, Cultured

1998
Cardiomyocyte apoptosis after antiviral WIN 54954 treatment in murine coxsackievirus B3 myocarditis.
    Scandinavian cardiovascular journal : SCJ, 2002, Volume: 36, Issue:3

    Topics: Animals; Antiviral Agents; Apoptosis; Enterovirus B, Human; Enterovirus Infections; Heart Ventricles; Isoxazoles; Mice; Mice, Inbred Strains; Myocarditis; Myocardium; Necrosis

2002
Potent antiviral agent WIN 54954: high specific activity labelling with tritium.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2004, Volume: 60, Issue:6

    Topics: Antiviral Agents; Indicators and Reagents; Isoxazoles; Radioisotope Dilution Technique; Tritium

2004